| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $16.75 | $0.00 | Buy | 9 | 2026 |
#2 | GENB | United States | $12.69 | $0.00 | Strong Buy | 6 | N/A |
#3 | RSI | United States | $24.93 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#4 | CARG | United States | $26.91 | $316,861,000.00 | Buy | 11 | 2017 |
#5 | FLYW | United States | $14.40 | $623,025,000.00 | Buy | 14 | 2021 |
#6 | DEC | United States | $14.10 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#7 | TBPH | United States | $15.93 | $15,386,000.00 | Buy | 6 | 2013 |
#8 | KNSA | United Kingdom | $47.59 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#9 | EYE | United States | $16.51 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#10 | OOMA | United States | $16.80 | $114,490,000.00 | Strong Buy | 4 | 2015 |
#11 | AORT | United States | $20.25 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#12 | CALX | United States | $38.67 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#13 | NTST | United States | $19.66 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#14 | PSTL | United States | $22.29 | $95,823,000.00 | Strong Buy | 4 | 2018 |
#15 | PFS | United States | $21.63 | $73,109,000.00 | Strong Buy | 4 | 2002 |
#16 | DCTH | United States | $10.36 | $0.00 | Strong Buy | 4 | 2015 |
#17 | NVST | United States | $22.70 | $2,566,500,000.00 | Buy | 13 | 2019 |
#18 | ALHC | United States | $14.39 | $3,948,719,000.00 | Buy | 8 | 2021 |
#19 | NMRK | United States | $14.03 | $3,294,024,000.00 | Buy | 5 | 2017 |
#20 | OMER | United States | $10.00 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#21 | CTRE | United States | $38.31 | $476,393,000.00 | Buy | 10 | 2013 |
#22 | STOK | United States | $29.28 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#23 | ASMB | United States | $24.23 | $0.00 | Strong Buy | 5 | 2010 |
#24 | KRUS | United States | $43.35 | $282,763,000.00 | Buy | 9 | 2019 |
#25 | PECO | United States | $39.27 | $726,594,000.00 | Buy | 7 | 2010 |
#26 | AROC | United States | $34.44 | $1,489,818,000.00 | Strong Buy | 6 | 2007 |
#27 | AVTX | United States | $13.88 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#28 | AMLX | United States | $13.25 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#29 | PRVA | United States | $20.53 | $2,122,842,000.00 | Buy | 12 | 2021 |
#30 | IDYA | United States | $28.23 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#31 | BSX | United States | $47.45 | $9,076,000,000.00 | Strong Buy | 22 | 2010 |
#32 | CSV | United States | $37.94 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#33 | SDRL | United States | $46.30 | $1,437,000,000.00 | Buy | 4 | 2018 |
#34 | HCSG | United States | $20.07 | $1,837,173,000.00 | Buy | 6 | 1994 |
#35 | IMNM | United States | $19.56 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#36 | HG | Bermuda | $28.85 | $2,905,524,000.00 | Buy | 8 | 2023 |
#37 | PAY | United States | $21.31 | $1,196,507,000.00 | Buy | 8 | 2021 |
#38 | CRVS | United States | $11.53 | $0.00 | Strong Buy | 6 | 2016 |
#39 | SKWD | United States | $43.14 | $1,416,541,000.00 | Buy | 8 | 2022 |
#40 | MLYS | United States | $24.93 | $0.00 | Strong Buy | 7 | 2023 |
#41 | ERAS | United States | $13.02 | $0.00 | Strong Buy | 12 | 2021 |
#42 | ZYME | United States | $24.03 | $105,965,000.00 | Strong Buy | 11 | 2022 |
#43 | SBH | United States | $12.19 | $3,701,424,000.00 | Buy | 6 | 2006 |
#44 | TRVI | United States | $13.40 | $0.00 | Strong Buy | 11 | 2019 |
#45 | ALLY | United States | $41.23 | $7,914,000,000.00 | Strong Buy | 13 | 2011 |
#46 | ENTA | United States | $11.36 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#47 | ZWS | United States | $47.14 | $1,530,500,000.00 | Buy | 6 | 2008 |
#48 | RVLV | United States | $18.90 | $1,225,682,000.00 | Buy | 12 | 2018 |
#49 | FNB | United States | $17.21 | $0.00 | Strong Buy | 5 | 2002 |
#50 | NI | United States | $45.95 | $0.00 | Buy | 10 | 2018 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $50 to Buy (June 3, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.